Efficacy of myofascial release techniques in the treatment of primary Raynaud's phenomenon

被引:11
|
作者
Walton, Anne [1 ]
机构
[1] Kine Concept Inst Ontario, 1800 Bank St,Suite 300, Ottawa, ON K1V 0W3, Canada
关键词
Primary Raynaud's phenomenon; Myofascial release; Fascia; Sympathetic nervous system; Vasospastic episodes;
D O I
10.1016/j.jbmt.2007.12.002
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: This study investigated whether myofascial release techniques performed on upper body connective tissue could mitigate the frequency, duration or pain intensity associated with primary Raynaud's phenomenon. Methods: Five treatments were administered over a 3-week treatment period on a 35-year-old female experiencing primary Raynaud's phenomenon for the past 12 years. A log was kept documenting frequency, duration and severity of pain. The myofascial work targeted the upper back, neck and arms according to hypothetical fascial meridian lines. Results: Symptom duration was the one characteristic that showed improvement. After the first treatment, the duration of the subject's vasospastic episodes was reduced by almost half and continued to decrease throughout the 3 weeks of treatments. Neither the frequency or number of affected digits varied significantly from the pre-treatment weeks. Conclusions: The results suggest that by releasing restricted fascia, myofascial techniques may influence the duration and severity of the vasospastic episodes experienced in primary Raynaud's phenomenon. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:274 / 280
页数:7
相关论文
共 50 条
  • [1] Treatment efficacy in secondary Raynaud's phenomenon
    Pauling, John D.
    Smith, Theresa
    Domsic, Robyn T.
    Frech, Tracy M.
    LANCET RHEUMATOLOGY, 2020, 2 (03): : E132 - E132
  • [2] Primary Raynaud's Phenomenon
    Rodgers, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (14): : 1344 - 1344
  • [3] Primary Raynaud's Phenomenon
    Alweis, Eliana A.
    Alweis, Richard L.
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2025, 15 (01):
  • [4] Primary Raynaud's phenomenon
    Beyong, Taso
    Ete, Tony
    Warjri, Synrang Batngen
    Barman, Bhupen
    NEW ZEALAND MEDICAL JOURNAL, 2015, 128 (1413) : 69 - 70
  • [5] Different Treatment Backgrounds Do Not Influence Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon
    Sulli, Alberto
    Goegan, Federica
    Gotelli, Emanuele
    Patane', Massimo
    Pizzorni, Carmen
    Paolino, Sabrina
    Alessandri, Elisa
    Ruaro, Barbara
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [6] PRAZOSIN TREATMENT OF PRIMARY RAYNAUD PHENOMENON
    NIELSEN, SL
    VITTING, K
    RASMUSSEN, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (03) : 421 - 423
  • [7] Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study
    Ruaro, Barbara
    Pizzorni, Carmen
    Paolino, Sabrina
    Alessandri, Elise
    Sulli, Alberto
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [8] Part II: The treatment of primary and secondary Raynaud's phenomenon
    Curtiss, Paul
    Svigos, Katerina
    Schwager, Zachary
    Lo Sicco, Kristen
    Franks, Anrdew G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (02) : 237 - 248
  • [9] Treatment of Raynaud's phenomenon
    Garcia-Carrasco, Mario
    Jimenez-Hernandez, Mario
    Escarcega, Ricardo O.
    Mendoza-Pinto, Claudia
    Pardo-Santos, Rodrigo
    Levy, Roger
    Maldonado, Claudio Galarza
    Perez Chavez, Gonzalo
    Cervera, Ricard
    AUTOIMMUNITY REVIEWS, 2008, 8 (01) : 62 - 68
  • [10] Treatment of Raynaud's phenomenon
    Fonollosa-Pla, V.
    Pilar Simeon-Aznar, C.
    Vilardell-Tarres, M.
    REVISTA CLINICA ESPANOLA, 2009, 209 (01): : 21 - 24